Connection

Lan-Juan Li to Influenza A Virus, H7N9 Subtype

Back to Details
This is a "connection" page, showing publications Lan-Juan Li has written about Influenza A Virus, H7N9 Subtype.
Lan-Juan Li
Connection Strength
2.151
Influenza A Virus, H7N9 Subtype
  1. The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice. Cell Physiol Biochem. 2018; 46(2):633-643.
    View in: PubMed
    Score: 0.508
  2. Disordered oropharyngeal microbial communities in H7N9 patients with or without secondary bacterial lung infection. Emerg Microbes Infect. 2017 Dec 20; 6(12):e112.
    View in: PubMed
    Score: 0.499
  3. Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Sci Rep. 2017 12 08; 7(1):17275.
    View in: PubMed
    Score: 0.497
  4. Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells. PLoS One. 2014; 9(3):e92823.
    View in: PubMed
    Score: 0.385
  5. State of the art-Artificial liver in China. Artif Organs. 2019 Apr; 43(4):336-341.
    View in: PubMed
    Score: 0.136
  6. Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus. Clin Infect Dis. 2018 03 19; 66(7):1054-1060.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.